India decriminalises minor device lapses
What happened
India's Parliament passed the Jan Vishwas Bill 2026, decriminalising hundreds of minor offences and shifting some procedural lapses — including certain medical‑device violations — from criminal penalties to civil fines. The change signals a move toward 'trust‑based governance' in a major market, altering enforcement philosophy but not removing expectations for documentation and corrective action. (moneycontrol.com)
Why it matters
Parliament completed passage of the Jan Vishwas (Amendment of Provisions) Bill, 2026 after it was introduced on March 27, 2026 and cleared the two Houses in the first week of April 2026; the legislation amends 784 provisions across 79 central Acts and removes criminal liability for 717 of those provisions. (prsindia.org) (mohfw.gov.in) For medical devices the change is concentrated in the Drugs & Cosmetics Act, 1940 and related health laws: a set of procedural defaults — for example failures in paperwork, local registration formalities, or record‑keeping — that could previously trigger criminal prosecution will now be handled as civil penalties or improvement notices; one worked example in the Bill replaces a previous criminal penalty for certain cosmetics offences with a civil penalty of Rs 1 lakh or three times the value of confiscated goods, whichever is higher. (moneycontrol.com) (newsonair.gov.in) The statute creates an administrative enforcement model rather than relying on criminal courts: central authorities will appoint adjudicating officers (senior officials charged with holding inquiries and imposing penalties), and it builds an appellate layer and time‑bound procedures for resolution; the text also mandates automatic revision of fines by 10% every three years. (prsindia.org) (egazette.gov.in) The Health Ministry and regulators stress that safeguards for public health remain in place and that serious violations affecting safety will continue to attract strict action rather than being treated as minor civil matters. (mohfw.gov.in) (ndtv.com) For post‑market safety operations this means a shift in likely enforcement tactics: expect more improvement notices, administrative inquiries, and civil‑penalty orders (with faster timelines) instead of long criminal prosecutions, and anticipate regulators using warnings or graded penalties for first and second contraventions before levying fines. (prsindia.org 1) (prsindia.org 2) Operational next steps that follow directly from these changes are concrete: catalogue which of your India product dossiers, manufacturing licences and vigilance records map to the Drugs & Cosmetics Act entries amended by the Bill; hard‑segment record retention and complaint timelines so evidence is immediately available for an adjudication officer; update escalation thresholds in local standard operating procedures to resolve corrective actions within the administrative timelines the Bill enables; and brief legal/regulatory counsel to model likely civil‑penalty exposure (including the new fine scale and automatic 10% triennial increases) for any open deviations. (prsindia.org 1) (prsindia.org 2)
Key numbers
- India's Parliament passed the Jan Vishwas Bill 2026, decriminalising hundreds of minor offences and shifting some procedural lapses — including certain medical‑device violations — from criminal penalties to civil fines.
What happens next
- (prsindia.org) (egazette.gov.in) The Health Ministry and regulators stress that safeguards for public health remain in place and that serious violations affecting safety will continue to attract strict action rather than being treated as minor civil matters.
Quick answers
What happened in India decriminalises minor device lapses?
India's Parliament passed the Jan Vishwas Bill 2026, decriminalising hundreds of minor offences and shifting some procedural lapses — including certain medical‑device violations — from criminal penalties to civil fines. The change signals a move toward 'trust‑based governance' in a major market, altering enforcement philosophy but not removing expectations for documentation and corrective action. (moneycontrol.com)
Why does India decriminalises minor device lapses matter?
Parliament completed passage of the Jan Vishwas (Amendment of Provisions) Bill, 2026 after it was introduced on March 27, 2026 and cleared the two Houses in the first week of April 2026; the legislation amends 784 provisions across 79 central Acts and removes criminal liability for 717 of those provisions. (prsindia.org) (mohfw.gov.in) For medical devices the change is concentrated in the Drugs & Cosmetics Act, 1940 and related health laws: a set of procedural defaults — for example failures in paperwork, local registration formalities, or record‑keeping — that could previously trigger criminal prosecution will now be handled as civil penalties or improvement notices; one worked example in the Bill replaces a previous criminal penalty for certain cosmetics offences with a civil penalty of Rs 1 lakh or three times the value of confiscated goods, whichever is higher. (moneycontrol.com) (newsonair.gov.in) The statute creates an administrative enforcement model rather than relying on criminal courts: central authorities will appoint adjudicating officers (senior officials charged with holding inquiries and imposing penalties), and it builds an appellate layer and time‑bound procedures for resolution; the text also mandates automatic revision of fines by 10% every three years. (prsindia.org) (egazette.gov.in) The Health Ministry and regulators stress that safeguards for public health remain in place and that serious violations affecting safety will continue to attract strict action rather than being treated as minor civil matters. (mohfw.gov.in) (ndtv.com) For post‑market safety operations this means a shift in likely enforcement tactics: expect more improvement notices, administrative inquiries, and civil‑penalty orders (with faster timelines) instead of long criminal prosecutions, and anticipate regulators using warnings or graded penalties for first and second contraventions before levying fines. (prsindia.org 1) (prsindia.org 2) Operational next steps that follow directly from these changes are concrete: catalogue which of your India product dossiers, manufacturing licences and vigilance records map to the Drugs & Cosmetics Act entries amended by the Bill; hard‑segment record retention and complaint timelines so evidence is immediately available for an adjudication officer; update escalation thresholds in local standard operating procedures to resolve corrective actions within the administrative timelines the Bill enables; and brief legal/regulatory counsel to model likely civil‑penalty exposure (including the new fine scale and automatic 10% triennial increases) for any open deviations. (prsindia.org 1) (prsindia.org 2)
